Notice2022-03555
Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-RFA-PS-22-001, Implementing Pre-Exposure Prophylaxis for HIV Prevention in Syringe Service Programs; RFA-PS-22-002, Implementation Research on Telehealth Strategies To Support Retention in Care and Treatment Among Antiretroviral Therapy (ART) Patients and Pre-Exposure Prophylaxis (PrEP) Clients and RFA-PS-22-004, Understanding HIV/STD Risk and Enhancing PrEP Implementation Messaging in a Diverse Community-Based Sample of Gay, Bisexual, and Other Men Who Have Sex With Men in a Transformational Era; Amended Notice of Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
February 18, 2022
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 34 (Friday, February 18, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 34 (Friday, February 18, 2022)]
[Notices]
[Page 9362]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-03555]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP)--RFA-PS-22-001, Implementing Pre-Exposure
Prophylaxis for HIV Prevention in Syringe Service Programs; RFA-PS-22-
002, Implementation Research on Telehealth Strategies To Support
Retention in Care and Treatment Among Antiretroviral Therapy (ART)
Patients and Pre-Exposure Prophylaxis (PrEP) Clients and RFA-PS-22-004,
Understanding HIV/STD Risk and Enhancing PrEP Implementation Messaging
in a Diverse Community-Based Sample of Gay, Bisexual, and Other Men Who
Have Sex With Men in a Transformational Era; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the Disease,
Disability, and Injury Prevention and Control Special Emphasis Panel
(SEP) RFA-PS-22-001, Implementing Pre-exposure Prophylaxis for HIV
Prevention in Syringe Service Programs; RFA-PS-22-002, Implementation
Research on Telehealth Strategies to support Retention in Care and
Treatment among Antiretroviral Therapy (ART) Patients and Pre-exposure
Prophylaxis (PrEP) Clients; and RFA-PS-22-004, Understanding HIV/STD
Risk and Enhancing PrEP Implementation Messaging in a Diverse
Community-Based Sample of Gay, Bisexual, and Other Men Who Have Sex
with Men in a Transformational Era.
Date: March 30, 2022.
Time: 10:00 a.m.-5:00 p.m. (EDT).
Place: Teleconference.
The meeting was published in the Federal Register on February 4,
2022, Volume 87, Number 24, page 6562-6563.
The meeting is being amended to remove RFA-PS-22-002,
Implementation Research on Telehealth Strategies to Support Retention
in Care and Treatment among Antiretroviral Therapy (ART) Patients and
Pre-exposure Prophylaxis (PrEP) Clients and should read as follows:
RFA-PS-22-001, Implementing Pre-exposure Prophylaxis for HIV
Prevention in Syringe Service Programs and RFA-PS-22-004, Understanding
HIV/STD Risk and Enhancing PrEP Implementation Messaging in a Diverse
Community-Based Sample of Gay, Bisexual, and Other Men Who Have Sex
with Men in a Transformational Era.
The meeting is closed to the public.
For Further Information Contact: Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, National Center for HIV, Viral Hepatitis,
STD, and TB Prevention, CDC, 1600 Clifton Road NE, Mailstop US8-1,
Atlanta, Georgia 30329, Telephone: (404) 718-8833, Email:
<a href="/cdn-cgi/l/email-protection#a6e1e7c8c2c3d4d5c9c8e6c5c2c588c1c9d0"><span class="__cf_email__" data-cfemail="4502042b212037362a2b052621266b222a33">[email protected]</span></a>.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-03555 Filed 2-17-22; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on February 18, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.